Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

434
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
434
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Surgical treatment of expiratory stenosis].

Khirurgiia·2026
Same author

[Surgery for benign tracheoesophageal fistula].

Khirurgiia·2026
Same author

[Surgery for recurrent benign tracheoesophageal fistula].

Khirurgiia·2026
Same author

[Temporary endoscopic occlusion of tracheoesophageal fistula prior to radical surgery].

Khirurgiia·2026
Same author

[Pulmonary artery surgery in thoracic oncology].

Khirurgiia·2025
Same author

[3D printing for airway stenting in patients with complex benign tracheobronchial stenosis].

Khirurgiia·2025

Related Experiment Video

Updated: Feb 8, 2026

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

1.6K

TREATMENT OF CHYLOTHORAX - ANESTHESIOLOGICAL OR SURGICAL PROBLEM?.

V D PRrhin, M A Vvzhiaina, A A Bunvatvan

    Anesteziologiia I Reanimatologiia
    |June 23, 2018
    PubMed
    Summary

    Chylothorax and chylorrhea treatment is crucial following thoracic surgery. Conservative therapy is effective for most cases, with surgery reserved for treatment failures.

    More Related Videos

    Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
    06:23

    Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

    Published on: May 23, 2021

    5.4K
    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
    06:04

    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

    Published on: March 6, 2018

    17.6K

    Related Experiment Videos

    Last Updated: Feb 8, 2026

    Surgical Treatment of an Endolymphatic Sac Tumor
    04:34

    Surgical Treatment of an Endolymphatic Sac Tumor

    Published on: May 26, 2023

    1.6K
    Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
    06:23

    Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

    Published on: May 23, 2021

    5.4K
    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
    06:04

    Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

    Published on: March 6, 2018

    17.6K

    Area of Science:

    • Thoracic Surgery
    • Surgical Complications
    • Lymphatic System Disorders

    Background:

    • Increased incidence of thoracic lymphatic duct trauma due to advancements in cardiac and thoracic surgery.
    • Growing clinical significance of managing chylothorax and chylorrhea.
    • Need for improved diagnostic and therapeutic strategies for these conditions.

    Purpose of the Study:

    • To enhance the diagnosis, prevention, and treatment outcomes for patients suffering from chylothorax and chylorrhea.
    • To evaluate the effectiveness of current management approaches.
    • To reduce the morbidity and mortality associated with thoracic duct injuries.

    Main Methods:

    • Retrospective analysis of 37 patients (14 female, 23 male) treated between 2004 and 2014.
    • Patients aged 32-71 years; 34 developed chylothorax post-surgery, 3 due to central venous catheterization complications.
    • Data collected on patient demographics, etiology, and treatment outcomes.

    Main Results:

    • Conservative therapy achieved a positive clinical effect in 83.8% of patients.
    • One patient mortality occurred due to pneumonia post-pneumonectomy with chylothorax.
    • Successful elimination of chylothorax in other cases with no late recurrences observed.

    Conclusions:

    • Surgeon experience is vital for preventing thoracic duct injury; securing the duct with surrounding tissue is recommended.
    • Conservative management is the primary treatment for chylothorax.
    • Surgical intervention is indicated for persistent cases (over two weeks) or significant chylorrhea.